echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Blood System > Blood: Small residual lesions predict prognosis in patients with mantle cell lymphoma in real time

    Blood: Small residual lesions predict prognosis in patients with mantle cell lymphoma in real time

    • Last Update: 2022-10-12
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    Prognosis in young patients with mantle cell lymphoma (MCL) has improved


    Minimal residual lesion (MRD) analysis is a known prognostic prediction tool


    Of the 300 patients enrolled, 250 (83%) all carried a molecular marker, allowing us to analyze



    ASCT induced polymer remission (91% in peripheral blood and 83% in bone marrow).


    To improve MRD performance, the researchers developed a time-changing model based on regularly updated MRD results and MIPI (International Prognostic Index for Mantle Cell Lymphoma), which showed an area of up to 0.


    In summary, MRD is a strong predictor throughout the natural history of MCL, applicable to models


    Original Source:

    Simone Ferrero, Daniele Grimaldi, Elisa Genuardi, et al.


    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.